Forward Surgical, Enroute Care, Shock, and Tissue Stabilization (FSECSTS)

The summary for the Forward Surgical, Enroute Care, Shock, and Tissue Stabilization (FSECSTS) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.

Forward Surgical, Enroute Care, Shock, and Tissue Stabilization (FSECSTS): Applications for the Combat Casualty Care Research Program are being solicited by the Assistant Secretary of Defense for Health Affairs, Defense Health Program (DHP). The Combat Casualty Care Research Program (CCCRP) provides resources for advances in biotechnology research administered by the Telemedicine and Advanced Technology Research Center (TATRC), located at Fort Detrick, Maryland. TATRC is administering the application process for this Program Announcement/Funding Opportunity, and the United States Army Medical Research Acquisition Activity (USAMRAA) is issuing this Program Announcement and will be negotiating all resulting awards. With this Program Announcement/Funding Opportunity, the US Army Medical Research and Materiel Command (USAMRMC) is seeking to fund biotechnology research that culminates in outcomes and technologies that may qualify as advanced development activities within the Department of Defense (DoD). The results of the research funded through this Program Announcement/Funding Opportunity are expected to increase the body of knowledge available to professionals and practitioners in health, medical science and related fields. The research impact is expected to benefit both civilian and military communities, particularly as it relates to the Priority Areas of Forward Surgical/Intensive Critical Care, EnRoute Care, Mechanisms of immune-modulatory protection after hemorrhagic shock using complement inhibition, T-cell depletion, or T-cell sequestration, and Metabolic and Tissue Stabilization.